Mr Giles Davies

About Giles

DSC 7941
About Giles

Mr Davies trained at St. Georges Hospital Medical School and was appointed consultant Oncoplastic Breast Surgeon at Kingston Hospital and the Royal Marsden Hospital in 2007. With over 20 years of surgical experience and over 500 patient reviews in the last three years Mr Davies has high quality outcomes from specialist cancer surgery. He’s built a bespoke team focusing on holistic cancer care with a particular focus on clinical exercise mental health sleep and Wellness. He’s held a variety of leadership roles and is currently undertaking a Masters Degree at Oxford University in Global Healthcare leadership which has led to a healthcare consulting practice, international roles in developing cancer services in India and advisory roles for technology startup companies. He works closely alongside Mahwash Babar, Consultant Oncoplastic Surgeon, specialist nurses and a team of three dedicated breast radiologists providing immediate rapid diagnostic breast clinic services every day of the week.

Additional Information

Scientific Papers

The Clinical Impact of Oncoplastic and Reconstructive Procedures in a Specialist Breast Practice. Kollias J, Bochner M, Davies G, Gill PG. Submitted for publication ANZ Journal of Surgery 2007

Surgeon performed ultrasound in combination with sestamibi; reliable preoperative investigations for surgeons planning MIP
Prasannan S., Davies G, Malycha P et al. Submitted for publication ANZ Journal of Surgery 2007

Erosive adenomatosis of the nipple – a report of 3 cases. Davies G. et al. Annals of Royal College of Surgeons of England 2004: 86. 146-147

Cyclooxygenase-2 and chemoprevention of breast cancer. Davies G. J Steroid Biochemistry and Molecular Biology 2003 Sep;86(3-5):495-9

Correlation between cyclooxygnenase-2 expression and angiogenesis in human breast cancer. Davies G. et al. Clinical Cancer Research 2003 Jul;9(7):2651-6

Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibition in breast cancer chemoprevention. Davies G. et al. Annals of Oncology 2002: 13

Jet-ski injury: severe blunt neck trauma with survival. Davies G. et al JRSM 2001 August: 94; 402-3

Effects of diadenosine phosphates on human umbilical vessels: novel platelet-derived vasoconstrictors. Davies G. et al. Brit. J. Clin. Pharm.: 1995; 40 : 170-172

The role of Cyclooxygenase-2 in breast cancer. Davies G., Sacks N.P.M. CME Breast August 2002

Meeting report ASCO 2002: Davies G. Expert Reviews of Anticancer Therapy 2002

“Sentinel lymph node biopsy in invasive breast cancer using 99mTc-Evans Blue dye.” G.Davies, M Green, J Kollias, G Gill, B Chatterton, C Tsopelas
Royal Australasian College of Surgeons 75th Annual Scientific Congress 15-19thMay 2006

“Cyclooxygenase-2 (COX-2) expression in human breast cancers – correlations with known biological variables and rationale for the use of COX-2 inhibitors” Davies G. et al. Poster and Discussion, American Society of Clinical Oncology, Orlando, Florida, USA 19th-23rd May 2002

“COX-2, biology and links with intratumoural aromatase” Invited oral presentation at Aromatase 2002 conference, Kyoto, Japan 26th-30th October 2002

“Current management of DCIS” Case presentation on behalf of the Academic Breast Unit Royal Marsden Hospital, 3rd European Breast Cancer Conference, Barcelona, Spain 2002

“Cyclooxygenase-2, aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention”: Presented at 7th Nottingham International Breast Cancer Conference, November 2001

“Simplifying Sentinel Node Biopsy in Breast Cancer: Blue dye alone is accurate”: Presented at the Royal Australasian College of Surgeons Annual Scientific Congress, Canberra, Australia 2001 (published as abstract in ANZ Journal of Surgery vol 71, May 2001)

“COX-2: Neoadjuvant studies”: Presented at 2nd Pharmacia Oncology UK Forum 15th-17th November 2001

“Jet-ski injury”: Presented at London Group of Paediatric Surgeons, Great Ormond Street Childrens Hospital 1999

Breast Biopsy: Davies G. Essential Womens Health Part 4, July 2001, Summertime Publishing

Mr Davies latest research update finds evidence of the presence of Human Papillomavirus (HPV) in breast cancer tissue

Presented in International Breast Cancer Immunotherapy Symposium Qatar 13th-14th April 2015

“Association of High Risk Human Papillomavirus (HPV) types with breast cancer: UK population based study”